oxybutynin has been researched along with Somatoform Disorders in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miotto, K | 1 |
| Kaufman, A | 1 |
| Kong, A | 1 |
| Jun, G | 1 |
| Schwartz, J | 1 |
1 other study available for oxybutynin and Somatoform Disorders
| Article | Year |
|---|---|
Managing co-occurring substance use and pain disorders.
Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Child; Chronic Pain; Diagnostic and | 2012 |